Eloxx Pharmaceuticals Inc ELOX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
0.3498quote price arrow up+0.0138 (+4.11%)
Volume
110,039
52 week range
0.21 - 2.53
Loading...
  • Open0.341
  • Day High0.36
  • Day Low0.33
  • Prev Close0.336
  • 52 Week High2.53
  • 52 Week High Date06/15/21
  • 52 Week Low0.21
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap30.31M
  • Shares Out86.65M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta2.37
  • YTD % Change-51.16

KEY STATS

  • Open0.341
  • Day High0.36
  • Day Low0.33
  • Prev Close0.336
  • 52 Week High2.53
  • 52 Week High Date06/15/21
  • 52 Week Low0.21
  • 52 Week Low Date05/12/22
  • Market Cap30.31M
  • Shares Out86.65M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta2.37
  • YTD % Change-51.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.93
  • P/E (TTM)-0.38
  • Fwd P/E (NTM)-0.77
  • EBITDA (TTM)-68.438M
  • ROE (TTM)-964.99%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)103.71%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eloxx Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing ribonucleic acid (RNA)-modulating drug candidates, each designed to be a eukaryotic ribosomal selective glycoside (ERSG), formulated to treat rare and ultra-rare premature stop codon diseases. The Company's lead product candidate, ELX-02, is a small molecule designed to restore production of full-length functional proteins. ELX-02 is in clinical development for...
Tomer Kariv J.D.
Independent Chairman of the Board
Sumit Aggarwal
President, Chief Executive Officer, Director
Daniel Geffken CPA
Interim Chief Financial Officer, Principal Accounting Officer
Address
480 ARSENAL WAY, SUITE 130
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
SYN
Synthetic Biologics Inc
0.2199+0.0016+0.73%
ADIL
Adial Pharmaceuticals Inc
1.40+0.04+2.94%
NNVC
NanoViricides Inc
2.14-0.46-17.69%
CLBS
Caladrius Biosciences Inc
0.46-0.0015-0.325%
ONCS
OncoSec Medical Inc
0.8043+0.0343+4.45%